TEVAR for TTAI was found to be safe (3 minimal complications) and effective both in the short and mid-long term. Patients' adherence to follow-up and contrast-induced kidney damage remains a challenge, but the use of MRI may be a valid alternative, avoiding ionizing radiation and the use of iodinated contrast media.
Fontana et al. (Tue,) studied this question.